Principal Investigator
Postdoctoral Researchers
I'm interested in using EAB sensors to understand neuropharmacology and individual variability in pharmacokinetics. My research aims to improve biosensors for application in clinical use and animal models.
I’m interested in understanding variability in risk for substance use disorders. My current research aims to investigate the relationship between drug concentrations in the brain and addiction-like behaviours in rat self-administration models.
Graduate Students
My interests involve adapting EAB sensors for subcutaneous application, in hopes of creating a viable, minimally invasive platform for the detection of both therapeutics and recreational drugs in vivo. My work primarily focuses on utilizing EAB sensors for the detection of drugs with narrow therapeutic drug windows, such as chemotherapeutics. With EAB sensors, I have been able to perform seconds-resolved, feedback-controlled drug delivery over plasma and in-brain drug levels.
My interests involve optimizing and expanding the use of electrochemical aptamer-based sensors (EABs) in subcutaneous tissue. I also integrate foundational electrochemical principles to optimize EAB sensors for in vivo use.
My interests are understanding drug pharmacokinetics and addiction using electrochemical aptamer-based biosensors in tandem with behavioral paradigms. My current research aims to explore drug pharmacokinetics during self-administration
I am primarily interested in exploring the utility of EAB (Electrochemical Aptamer-Based) sensors for neuropharmacology in rodents, in the hopes of getting a better understanding of addiction models and underlying circuitry.